Sequent-Viyash amalgamation scheme effective, 18.19 crore shares allotted

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

VIYASH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹211.29

prior close

₹210.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.9%+0.4% vs market

Pharmaceuticals peers, median of 156sector-0.8%+0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.8

15m

+0.6

30m

+2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5-0.9+0.4-0.8+0.3

Next day

-1.1-1.2+0.1-0.9-0.2

-0.4+0.0-0.5-0.0-0.4

+3.4+1.4+2.0+0.2+3.2

+2.8+1.5+1.3+0.5+2.3

+1.2+0.9+0.3+0.0+1.2

-1.4-0.4-1.0-0.8-0.6

15d

-5.3-0.3-5.1-0.3-5.1

-2.7-4.2+1.5-3.7+1.0

+4.1-1.7+5.8-3.7+7.9

-9.6-11.4+1.8-11.3+1.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sequent Scientific's NCLT-sanctioned composite scheme of amalgamation with Viyash and other entities became effective on Dec 16, 2025. Company allotted 18.19 crore equity shares to Viyash shareholders at 56:100 exchange ratio, plus 2.03 crore warrants at Rs 181.94 each. Paid-up capital rises to Rs 87.2 crore from Rs 50.8 crore. New MD Dr. Haribabu Bodepudi appointed; new CFO from Jan 1, 2026. CA Hull Investments becomes a promoter.

Likely market impact

Share dilution from large equity issuance, but expanded operations and stronger leadership. Warrants add potential further dilution if converted.